PathMaker launches 1st human trial to test noninvasive ALS device | Phase 1 trial of MyoRegulator funded by MDA, CERF and NIH alsnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alsnewstoday.com Daily Mail and Mail on Sunday newspapers.
BOSTON and NEW YORK, Jan. 17, 2023("PathMaker"), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of serious neurological disorders, announced